Berenberg Bank initiated coverage on shares of Novozymes A/S (OTCMKTS:NVZMY) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the stock.

Novozymes A/S (OTCMKTS:NVZMY) opened at 43.185 on Tuesday. The company’s 50 day moving average is $43.67 and its 200 day moving average is $46.08. Novozymes A/S has a 12-month low of $37.98 and a 12-month high of $49.55. The company has a market cap of $12.97 billion, a price-to-earnings ratio of 30.220 and a beta of 0.70.

About Novozymes A/S

Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. In June 2013, the Company restructured its sales areas within those segments. The Household Care (old Household Care Enzymes) area comprises cleaning solutions, laundry, dishwashing and microorganism sales for cleaning solutions.

Receive News & Stock Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related stocks with our FREE daily email newsletter.